NCT00483561 2023-09-13Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone TherapyUniversity of NebraskaPhase 2 Terminated26 enrolled 7 charts
NCT00085566 2016-01-20Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate CancerMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed61 enrolled 8 charts